Compare BBIO & CLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBIO | CLX |
|---|---|---|
| Founded | 2015 | 1913 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 12.4B |
| IPO Year | 2019 | 1994 |
| Metric | BBIO | CLX |
|---|---|---|
| Price | $69.63 | $95.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 25 | 12 |
| Target Price | $86.04 | ★ $110.25 |
| AVG Volume (30 Days) | 1.7M | ★ 2.1M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.13% |
| EPS Growth | N/A | ★ 189.78 |
| EPS | N/A | ★ 1.93 |
| Revenue | $502,076,000.00 | ★ $6,124,000,000.00 |
| Revenue This Year | $89.45 | N/A |
| Revenue Next Year | $73.78 | $8.64 |
| P/E Ratio | ★ N/A | $50.14 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $31.77 | $96.36 |
| 52 Week High | $84.94 | $142.38 |
| Indicator | BBIO | CLX |
|---|---|---|
| Relative Strength Index (RSI) | 40.40 | 34.88 |
| Support Level | $61.95 | N/A |
| Resistance Level | $78.96 | $108.54 |
| Average True Range (ATR) | 4.00 | 2.80 |
| MACD | -0.72 | -0.33 |
| Stochastic Oscillator | 2.54 | 4.48 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.